Lataa...
Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?
Surgical resection remains the only treatment that offers a potential chance of long-term survival. Unfortunately, about 80% of patients treated with curative intent will develop recurrence. Since 2001, adjuvant therapy with gemcitabine or 5-fluorouracyle was recommended. This approach allows a medi...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826876/ https://ncbi.nlm.nih.gov/pubmed/31614884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101547 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|